Neuroleptics and Constipation: ANSM Issues New Warning on Severe Risks
The French National Agency for the Safety of Medicines (ANSM) issued a new alert on June 11, 2026, regarding the risk of severe constipation in patients treated with neuroleptics. These antipsychotic medications, while essential for managing conditions like schizophrenia and bipolar disorder, carry anticholinergic properties that can significantly slow intestinal transit. The agency warns that this side effect, if ignored, can lead to life-threatening complications, including intestinal obstruction, perforation, and severe abdominal infection.
Did You Know? The risk of constipation is not limited to a single medication; according to the ANSM, it can affect the entire class of neuroleptics, though some drugs carry a higher risk due to more pronounced anticholinergic effects.
Why neuroleptics cause digestive complications
Neuroleptics function primarily by acting on brain neurotransmitters to reduce symptoms of agitation, hallucinations, and delusions. However, their pharmacological action extends beyond the central nervous system. Because many of these drugs possess anticholinergic properties, they interfere with the body’s automatic functions, including the natural muscular movements of the intestines.
When these movements slow down, stool remains in the colon for extended periods. As it stagnates, it loses moisture and becomes increasingly difficult to evacuate. The ANSM emphasizes that this process is not merely a digestive inconvenience but a physiological chain reaction that can progress from simple constipation to a total blockage of the digestive tract.
Risks for patients over 60
Patients aged 60 and older face a heightened risk of severe complications when taking neuroleptics. Aging naturally slows intestinal transit, and elderly patients are more likely to be affected by secondary factors such as reduced physical activity, insufficient hydration, and the use of multiple medications that can further impair bowel function.
The ANSM notes that these patients may also struggle to communicate early warning signs, particularly if they suffer from existing cognitive or neurological conditions. Because the symptoms of constipation—such as a bloated abdomen or abdominal pain—are often dismissed as common occurrences in older populations, the agency urges caregivers and family members to maintain vigilant monitoring.
Expert Insight: The clinical challenge here lies in the “masking” of symptoms. Because neuroleptics are essential for stabilizing severe psychiatric conditions, the focus remains on mental health, often causing physical symptoms like constipation to be overlooked until they reach a critical stage. The trade-off between psychiatric stability and gastrointestinal health requires a proactive, rather than reactive, approach to patient monitoring.
Signs that require medical attention
The ANSM advises that any digestive change occurring during neuroleptic treatment should be taken seriously. Patients or their caregivers should seek medical consultation if they observe an absence of bowel movements, worsening constipation, significant abdominal pain, or a tense, swollen belly. Other concerning symptoms include nausea, vomiting, fever, or unexplained diarrhea, which can sometimes mask a severe underlying blockage.
What happens next for patients
While the ANSM has issued a formal warning, it explicitly advises patients never to stop their medication without consulting a doctor. Abruptly discontinuing neuroleptics can lead to a return of psychiatric symptoms or a dangerous destabilization of the patient’s health. Future management is expected to focus on early prevention, with doctors screening for digestive history, sedentary habits, and fiber intake before prescribing these treatments. In cases where constipation persists, clinicians will likely evaluate the need to adjust dosages or implement additional measures to support transit, ensuring the patient remains safe while continuing necessary psychiatric care.
Frequently Asked Questions
Should I stop taking my medication if I experience constipation?
No. The ANSM states that patients must never interrupt their treatment without medical advice, as this can cause a relapse of psychiatric symptoms. You should consult a health professional to evaluate your specific situation.
Which symptoms are considered warning signs of a serious complication?
Warning signs include prolonged absence of bowel movements, severe abdominal pain, a swollen or tense abdomen, nausea, vomiting, fever, or unexplained diarrhea.
Why are elderly patients more vulnerable to this side effect?
Patients over 60 often have naturally slower transit times, lower activity levels, and are frequently taking multiple medications, all of which compound the anticholinergic effects of neuroleptics.
How are you and your healthcare provider currently monitoring your digestive health while managing your treatment plan?